A citation-based method for searching scientific literature

Louise Heiniger, Melanie A Price, Margaret Charles, Phyllis N Butow. J Genet Couns 2015
Times Cited: 6







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.
Kristi D Graves, Patti Vegella, Elizabeth A Poggi, Beth N Peshkin, Angie Tong, Claudine Isaacs, Clinton Finch, Scott Kelly, Kathryn L Taylor, George Luta,[...]. Cancer Epidemiol Biomarkers Prev 2012
54
33

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
174
33

Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing.
Uta Francke, Cheri Dijamco, Amy K Kiefer, Nicholas Eriksson, Bianca Moiseff, Joyce Y Tung, Joanna L Mountain. PeerJ 2013
49
33

Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.
Kate Brunstrom, Alexandra Murray, Marion McAllister. J Genet Couns 2016
24
33

Cultural aspects of healthy BRCA carriers from two ethnocultural groups.
Alicia Navarro de Souza, Danielle Groleau, Carmen G Loiselle, William D Foulkes, Nora Wong. Qual Health Res 2014
10
33

Sources of uncertainty about daughters' breast cancer risk that emerge during genetic counseling consultations.
Carma L Bylund, Carla L Fisher, Dale Brashers, Shawna Edgerson, Emily A Glogowski, Sherry R Boyar, Yelena Kemel, Sara Spencer, David Kissane. J Genet Couns 2012
28
33

Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment.
Cheryl B Crotser, Suzanne S Dickerson. J Nurs Scholarsh 2010
14
33

Psychometric characteristics of the Multidimensional Scale of Perceived Social Support.
G D Zimet, S S Powell, G K Farley, S Werkman, K A Berkoff. J Pers Assess 1990
945
33

Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
Sari Lieberman, Ariela Tomer, Avi Ben-Chetrit, Oded Olsha, Shalom Strano, Rachel Beeri, Sivan Koka, Hila Fridman, Karen Djemal, Itzhak Glick,[...]. Genet Med 2017
26
16


Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Joanne Armstrong, Michele Toscano, Nancy Kotchko, Sue Friedman, Marc D Schwartz, Katherine S Virgo, Kristian Lynch, James E Andrews, Claudia X Aguado Loi, Joseph E Bauer,[...]. JAMA Oncol 2015
79
16

Factors affecting performance of prenatal genetic testing by Israeli Jewish women.
Carron Sher, Orly Romano-Zelekha, Manfred S Green, Tamy Shohat. Am J Med Genet A 2003
49
16

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
16

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?
Matthew B Yurgelun, Elaine Hiller, Judy E Garber. J Clin Oncol 2015
37
16

Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Heidi D Nelson, Miranda Pappas, Amy Cantor, Jessica Griffin, Monica Daeges, Linda Humphrey. Ann Intern Med 2016
195
16

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
16

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
Eric Rosenthal, Kelsey Moyes, Christopher Arnell, Brent Evans, Richard J Wenstrup. Breast Cancer Res Treat 2015
27
16

Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
238
16

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
630
16

Population genetic screening programmes: principles, techniques, practices, and policies.
Béatrice Godard, Leo ten Kate, Gerry Evers-Kiebooms, Ségolène Aymé. Eur J Hum Genet 2003
84
16

Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.
Johanna Ringwald, Christina Wochnowski, Kristin Bosse, Katrin Elisabeth Giel, Norbert Schäffeler, Stephan Zipfel, Martin Teufel. J Genet Couns 2016
40
16


Clinicians' attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations.
S Shkedi-Rafid, G Ofer-Bialer, V Meiner, R Calderon-Margalit. Public Health Genomics 2013
4
25


Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.
Kelly A Metcalfe, Aletta Poll, Robert Royer, Marcia Llacuachaqui, Anna Tulman, Ping Sun, Steven A Narod. J Clin Oncol 2010
113
16

Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system.
Sharon S Laing, Andy Bogart, Jessica Chubak, Sharon Fuller, Beverly B Green. Cancer Epidemiol Biomarkers Prev 2014
21
16

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
109
16

Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
Claire E Wakefield, Bettina Meiser, Judi Homewood, Robyn Ward, Sheridan O'Donnell, Judy Kirk. Cancer 2008
43
16

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
544
16


Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
63
16

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
193
16

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
100
16



Living with genetic test results for hereditary breast and ovarian cancer.
Rebekah Hamilton, Janet K Williams, Heather Skirton, Barbara J Bowers. J Nurs Scholarsh 2009
29
16

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
16

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004
120
16

Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers.
Gillian W Hooker, Lesley King, Lauren Vanhusen, Kristi Graves, Beth N Peshkin, Claudine Isaacs, Kathryn L Taylor, Elizabeth Poggi, Marc D Schwartz. Hered Cancer Clin Pract 2014
20
16


Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.
A Fuchsia Howard, Joan L Bottorff, Lynda G Balneaves, Charmaine Kim-Sing. BMC Womens Health 2010
21
16


Fertility intentions following testing for a BRCA1 gene mutation.
Ken R Smith, Lee Ellington, Anna Y Chan, Robert T Croyle, Jeffrey R Botkin. Cancer Epidemiol Biomarkers Prev 2004
43
16

Decision support: helping patients and families to find a balance at the end of life.
Mary Ann Murray, Toba Miller, Valerie Fiset, Annette O'Connor, Mary Jane Jacobsen. Int J Palliat Nurs 2004
40
16

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
K A Phillips, E Warner, W S Meschino, J Hunter, M Abdolell, G Glendon, I L Andrulis, P J Goodwin. Clin Genet 2000
38
16

Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women.
C M Julian-Reynier, L J Bouchard, D G Evans, F A Eisinger, W D Foulkes, B Kerr, I R Blancquaert, J P Moatti, H H Sobol. Cancer 2001
71
16

What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.
Danielle Campfield Bonadies, Anne Moyer, Ellen T Matloff. Fam Cancer 2011
39
16

Preliminary report of the relationship between experience of death of a relative, illness perception, and psychological outcome among BRCA carriers.
Dikla Samama, Ilanit Hasson-Ohayon, Shlomit Perry, Ofir Morag, Gil Goldzweig. Psychol Health Med 2014
5
20


Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing.
Vardit Kram, Tamar Peretz, Michal Sagi. Fam Cancer 2006
24
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.